1. Classification Criteria for axSpA

2. Differential Presentation of axSpA in Women vs Men

3. bDMARDs Approved by the European Medicines Agency (EMA) for axSpA

4. Pivotal RCTs for TNF Inhibitors in AS

5. C-axSpAnd: Phase 3 Study Evaluating Certolizumab Pegol vs Conventional Standard of Care Treatment in nr-axSpA

6. RAPID-axSpA: Certolizumab Pegol and Extra Spinal Manifestations

7. Use of TNF Inhibitors in Clinical Practice in Pregnant and Lactating Patients

8. Anti-TNF Treatment Prescription for WoCBA Patients With Chronic Inflammatory Diseases

9. Women With Chronic Rheumatic Diseases and Family Planning

10. Overarching Principles for Use of Antirheumatic Drugs Before and During Pregnancy

11. Abbreviations